Your session is about to expire
← Back to Search
Fenretinide for T-Cell Lymphoma
Study Summary
This trial is testing a new drug to treat T-cell non-Hodgkin's lymphoma, a cancer of the immune system.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have previously been treated with fenretinide.I have or had a brain or spinal cord disease.I do not have any uncontrolled illnesses.I have at least one tumor that can be measured.I am currently taking other medications.I use certain medications like acetaminophen carefully and under close watch.My lymphoma is at a specific stage and affects the skin or lymph nodes.My condition has not improved or has returned after treatment.I do not have an active hepatitis infection.It has been over 4 weeks since my last cancer treatment.I am HIV-positive and on combination antiretroviral therapy.My condition did not improve after two different drug treatments.I need treatment with strong CYP3A inducers.I need treatment with strong to moderate CYP3A inhibitors.I have a diagnosed eye condition.My diagnosis is a specific type of T-cell lymphoma confirmed by lab tests.I have not had chemotherapy or radiotherapy recently.My lymphoma is not one of the specified T-cell types.I am 18 years old or older.I am fully active or can carry out light work.My organs and bone marrow are functioning normally.I will use barrier methods of contraception if my partner can have children.
- Group 1: Phase 1
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Has the FDA sanctioned Fenretinide for use?
"Given the limited existing data on efficacy and safety, fenretinide is given a score of 1."
How many participants have been enrolled in this experiment?
"Currently, this trial is no longer recruiting. The final update to the study was made on October 24th 2022. For those still looking for a clinical trial related to mycosis fungoides, there are 1796 available studies and two trials actively enrolling participants who wish to receive fenretinide treatment."
Does this investigation represent a pioneering endeavor?
"Fenretinide has been under clinical investigation since 2020, when Laurent Pharmaceuticals Inc. conducted the first trial with 508 participants. Subsequently, it was approved for Phase 2 and 3 trials and there are currently two active studies spanning 28 cities in two different nations."
Is the recruitment for this experiment still ongoing?
"This clinical trial closed its recruitment phase on October 24th 2022. If you're searching for alternative studies, 1796 investigations into mycosis fungoides are actively recruiting and 2 trials of Fenretinide have open participant slots."
Could you elaborate on the history of Fenretinide trials that have been conducted?
"Presently, two medical trials are underway to further explore the effects of Fenretinide with one trial being in phase 3. Most of these studies for this compound take place in Winston-Salem but there is a network encompassing 33 sites conducting experiments on it."
Who else is applying?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger